Beijing has begun accepting vaccination records from people who intend to travel to China to receive the new crown vaccine made by a U.S. pharmaceutical company in the United States. Reuters said this means that China is beginning to relax its travel requirements.
Beijing has begun accepting records of vaccinations in the U.S. for people who want to travel to China to receive the New Crown vaccine from a U.S. pharmaceutical company. In an April 16 notice, the Chinese Embassy in the United States said it is still responsible for reviewing “double testing” certificates for passengers traveling to China on flights from Dallas, according to a Reuters report today. Those who have received inactivated vaccines and tested negative for nucleic acid and positive for IgM antibodies may apply for a health code as normal.
According to the notice, the existing Pfizer, Moderna, and Johnson & Johnson (J&J) vaccines in the United States are non-inactivated vaccines. As required, Pfizer and Moderna vaccines require two doses and Johnson & Johnson vaccine requires one dose. If you choose to travel to China, you must arrange your travel to China after completing the required number of vaccinations. (here)
Reuters said the guidance means travel requirements are beginning to be relaxed.
China has not approved vaccines developed by non-Chinese drugmakers for domestic use. But the Wall Street Journal reported Friday that China plans to approve the use of BioNTech’s New Crown vaccine by July.
Recent Comments